fbpx
Follow Us
954-421-3200

Mohs Micrographic Surgery may have higher survival for invasive Melanomas on the Head and Neck

|Comments are Off
According to a study published in the Journal of the American Academy of Dermatology, patients who were treated with Mohs’ Micrographic Surgery had a higher 5-year survival rate than those treated with excision. Despite this, many insurance carriers do not view Mohs’...

NEW MELANOMA DRUG LOOKS PROMISING FOR STAGE III AND IV MELANOMA PATIENTS

|Comments are Off
51% Of Patients Benefited In Phase II Trial. Forbes (10/30, Fortonbury) reports that in a study published in Annals of Surgical Oncology, a new cancer drug, PV-10, 51% of stage III and IV melanoma patients benefited during a phase II trial, and achieved total cancer disappearance...

Drug Approved for Inoperable Melanoma

|Comments are Off
Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.